Company / Revenue per Share
Amneal Pharmaceuticals, Inc. Revenue per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$17.14
FY2025
5-year range
$12.31 / $18.51
FY2021-FY2025
Trend
-7.4%
vs FY2024
Sector context
#29 of 154
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s revenue per share of $17.14 is higher than 81% of companies in the Health Care sector (FY2025). Revenue per Share has fluctuated over the past 9 years, ranging from $8.00 in FY2018 to $1033654.00 in FY2017.
Based on SEC 10-K filings.
17.14 in FY2025 with a 5-year CAGR of +5.6%. Top quartile in the Health Care sector.
Improved from $13.79 to $17.14 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +4.9%
- 5-Year CAGR
- +5.6%
- 10-Year CAGR
- -
Sector benchmark
+13.6% above sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 7.4% year-over-year.
- Ranks #29 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2017.
- Lowest revenue per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.14 | -7.4% |
| FY2024 | $18.51 | +34.2% |
| FY2023 | $13.79 | -7.2% |
| FY2022 | $14.86 | +20.7% |
| FY2021 | $12.31 | -5.8% |
| FY2020 | $13.07 | +60.9% |
| FY2019 | $8.12 | +1.5% |
| FY2018 | $8.00 | -100.0% |
| FY2017 | $1033654.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026